Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis

This study has been terminated.
(Hyperintensities of unclear etiology on brain MRI. Follow up revealed no progression.)
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Tufts Medical Center
ClinicalTrials.gov Identifier:
NCT00868751
First received: March 24, 2009
Last updated: December 6, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)